Herbas VPB

Print
EN | LT
LT - USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
EN - USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/01
A61K 38/03
A61K 38/04
A61P 9/00
A61P 11/00
A61P 17/00
A61P 25/00
A61P 31/12
A61P 37/00
European patent
(11) Number of the document 2296684
(13) Kind of document T
(96) European patent application number 09753692.4
Date of filing the European patent application 2009-06-02
(97) Date of publication of the European application 2011-03-23
(45) Date of publication and mention of the grant of the patent 2012-12-05
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2009/003935
Date 2009-06-02
PCT application publication
(87) Number WO 2009/144037
Date 2009-12-03
Priority applications
(30) Number Date Country code
PCT/EP2008/0043 2008-05-30 WO
Inventors
(72)
BONNY, Christophe, CH
Grantee
(73) Xigen S.A., Route de la Corniche 4, 1066 Epalinges, CH
Title
(54) USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES
  USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES